Evaluation of renal microcirculation by contrast-enhanced ultrasound with sonazoid™ as a contrast agent: Comparison between normal subjects and patients with chronic kidney disease

International Heart Journal

Volumn 51, Issue 3, 2010, Pages 176-182

  Tsuruoka, Kayori ^a   Yasuda, Takashi ^a   Koitabashi, Kenichiro ^a   Yazawa, Masahiko ^a   Shimazaki, Minako ^a   Sakurada, Tsutomu ^a   Shirai, Sayuri ^a   Shibagaki, Yugo ^a   Kimura, Kenjiro ^a   Tsujimoto, Fumio ^b  

^a Internal Medicine   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardio renal correlation; Cardiovascular disease (CVD); Chronic kidney disease (CKD); Contrast enhanced ultrasound (CEUS); Renal cortex; Renal medulla; Renal microcirculation; Second generation contrast agent; Time intensity curve; Visualization of renal vasculature

Indexed keywords

PERFLUBUTANE; CONTRAST MEDIUM; FERRIC ION; IRON; OXIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; KIDNEY CIRCULATION; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PERFUSION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PRIORITY JOURNAL; ULTRASOUND; CHRONIC DISEASE; COMPLICATION; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC USE; DOPPLER FLOWMETRY; ECHOGRAPHY; IMAGE ENHANCEMENT; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; HUMANS; IMAGE ENHANCEMENT; IRON; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY MEDULLA; MALE; MICROCIRCULATION; MIDDLE AGED; OXIDES; RENAL CIRCULATION; ULTRASONOGRAPHY, DOPPLER; YOUNG ADULT;

EID: 77954979634     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.176     Document Type: Article

References (16)

1. Parikh NI, Hwang SJ, Larson MG, Levy D, Fox CS. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2008; 02: 47-53.
2. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci 1963; 107: 539-56.
3. Brosius FC 3rd, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 2006; 114: 1083-7.
4. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25. (Review)
5. Schwarz KQ, Becher H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R. Doppler enhancement with SH U 508A in multiple vascular regions. Radiology 1994; 193: 195-201.
6. Bohle A, Müller GA, Wehrmann M, Mackensen-Haen S, Xiao JC. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 1996; 54: S2-9. (Review)
7. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and infuences long-term function. Am J Physiol Renal Physiol 2001; 281: F887-99.
8. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: fnal common pathways to end-stage renal failure. Intern Med 2004; 43: 9-17. (Review)
9. Sánchez-Lozada LG, Tapia E, Johnson RJ, RodrÍguez-Iturbe B, Herrera-Acosta J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial infammation. Kidney Int Suppl 2003; (86): S9-14. (Review)
10. Fischer T, Filimonow S, Dieckhofer J, et al. Improved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer--a new method for the diagnosis of renal per-fusion. Nephrol Dial Transplant 2006; 21: 2921-9.
11. Correas JM, Claudon M, Tranquart F, Hélénon AO. The kidney: imaging with microbubble contrast agents. Ultrasound Q 2006; 22: 53-66. (Review)
12. Iseki K. Chronic kidney disease in Japan. Intern Med 2008; 47: 681-9. (Review)
13. Hosotani Y, Takahashi N, Kiyomoto H, et al. A new method for evaluation of split renal cortical blood fow with contrast ech-ography. Hypertens Res 2002; 25: 77-83.
14. Landmark KE, Johansen PW, Johnson JA, Johansen B, Uran S, Skotland T. Pharmacokinetics of perfuorobutane following intravenous bolus injection and continuous infusion of sonazoid in healthy volunteers and in patients with reduced pulmonary diffusing capacity. Ultrasound Med Biol 2008; 34: 494-501.
15. Sontum PC. Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol 2008; 34: 824-33.
16. Toft KG, Hustvedt SO, Hals PA, et al. Disposition of perfuor-obutane in rats after intravenous injection of Sonazoid. Ultrasound Med Biol 2006; 32: 107-14.